Study guide
1.3 Blueprint, Scoring, Retakes, and Study Strategy
Connecticut Multistate Pharmacy Jurisprudence Examination CT MPJE
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the Connecticut MPJE 1.2 Application, Fees, ATT, and Pearson VUE 1.3 Blueprint, Scoring, Retakes, and Study Strategy
2 Connecticut Regulatory Structure
2.1 DCP and the Commission of Pharmacy 2.2 Chapter 400j, 420b/420c, and RCSA 20-576 2.3 Federal vs Connecticut Law (More Restrictive Rule)
3 Pharmacist Licensure, Interns, PIC, and CE
3.1 Pharmacist Qualifications and Exam Path 3.2 Interns, Score Transfer, and Reciprocity 3.3 Pharmacist-in-Charge / Pharmacist Manager 3.4 License Renewal and Continuing Education
4 Technicians and Non-Pharmacist Personnel
4.1 Technician Registration and Certification 4.2 Community Technician Ratios (20-576-36) 4.3 Institutional Ratios and Advanced Pharmacy Technicians 4.4 Technician Limitations, Interns, and Unlicensed Staff
5 Discipline, Impairment, and Unlicensed Practice
5.1 Disciplinary Grounds (CGS § 20-579) 5.2 Impaired Practitioner Reporting and Programs 5.3 Unlicensed Practice, Penalties, and Appeals
6 Federal Drug Law Foundations
6.1 FDCA, Adulteration, and Misbranding 6.2 FDA Approval, Recalls, and OTC vs Rx 6.3 DSCSA, HIPAA, OBRA ’90, and PPPA
7 Federal Controlled Substances
7.1 CSA Schedules and Definitions 7.2 DEA Registration and Forms 222, 106, 41 7.3 Federal Controlled-Substance Prescription Rules 7.4 Inventory, Theft, Loss, and Disposal
8 Prescription Issuance in Connecticut
8.1 Who May Prescribe in Connecticut 8.2 Noncontrolled Prescription Form and Content 8.3 Controlled Prescriptions and the EPCS Mandate
9 Refills, Partial Fills, and Opioid Limits
9.1 Refill Authority (Noncontrolled and CIII–V) 9.2 Partial Fills of Schedule II Prescriptions 9.3 Connecticut Opioid Supply Limits (7-day / 5-day)
10 Administration, CDTM, and Standing Orders
10.1 Pharmacist Immunization Authority 10.2 Collaborative Drug Therapy Management 10.3 Naloxone and Opioid Antagonist Access 10.4 Emergency and Hormonal Contraception
11 Counseling, Confidentiality, and Returns
11.1 Counseling and Offer to Counsel 11.2 HIPAA and Connecticut Confidentiality 11.3 Return, Reuse, and Take-Back
12 Corresponding Responsibility and DUR
12.1 Corresponding Responsibility and Legitimate Medical Purpose 12.2 Prospective Drug Utilization Review 12.3 Exceptions and Conditions Prohibiting Dispensing
13 Transfers, Labeling, Packaging, and Delivery
13.1 Transferring Prescriptions 13.2 Labeling of Dispensed Drugs 13.3 Packaging and the Poison Prevention Packaging Act 13.4 Delivery of Drugs
14 CPMRS, Substitution, and Nonprescription Drugs
14.1 CPMRS Query and Reporting 14.2 Generic and Biosimilar Substitution 14.3 CMEA and Behind-the-Counter Products 14.4 OTC Labeling, Hazardous, and Restricted Nonprescription Drugs
15 Ordering, Records, and Inventories
15.1 Ordering and Acquisition (DEA 222/CSOS) 15.2 Distribution and DSCSA Records 15.3 Recordkeeping Content and Three-Year Retention 15.4 Controlled-Substance Inventories and CT Perpetual CII
16 Storage, Security, and Hazardous Drugs
16.1 Controlled-Substance Storage and Security 16.2 Hazardous Drugs (USP <800>, NIOSH) 16.3 Non-Pharmacist Access to Drugs
17 Compounding and Central Fill
17.1 Nonsterile Compounding (USP <795>, RCSA 20-576-69) 17.2 Sterile Compounding (USP <797>, RCSA 20-576-64) 17.3 Central Fill, 503A, and 503B Outsourcing
18 Pharmacy Permits and Practice Settings
18.1 Pharmacy License, Hours, Manager, and Signage 18.2 Nonresident, Hospital, Nuclear, and Automated Dispensing 18.3 Inspection, Closure, and Facility Discipline
1.3 Blueprint, Scoring, Retakes, and Study Strategy
Key Takeaways Explain This Topic AI
For MPJE administrations before March 1, 2027, NABP’s Competency Statements weight four areas: Licensure/Personnel 22%, Pharmacist Practice 33%, Dispensing Requirements 24%, and Pharmacy Operations 21%.
NABP makes no distinction between federal and state items; answer under the prevailing law of Connecticut. When federal and Connecticut requirements conflict, the more restrictive rule controls — the central MPJE heuristic.
The passing standard is a scaled score of 75 on a 0–100 scale. Candidates typically see Pass or Fail in NABP e-Profile (often within 14 business days). A Fail result includes a competency-area performance report; a Pass does not.
A failed CT MPJE requires a mandatory 30-day wait, a new $100 eligibility application and $170 exam purchase, and counts toward NABP’s maximum of 5 attempts per jurisdiction.
Study federal pharmacy law together with CGS Chapter 400j, RCSA 20-576, CGS Chapters 420b and 420c, CPMRS rules, and Connecticut opioid limits, using DCP’s Comprehensive Drug Laws and NABP’s Competency Statements as the official maps.
Last updated: August 2026
The 2026 blueprint: four Competency Statement areas
Until March 1, 2027 , the Connecticut MPJE is built from NABP’s MPJE Competency Statements , not from the newer MPJE Content Outline. The Statements are the only official topic map you should use to allocate study time in 2026. They are organized in four areas. Weights are percentages of the scored exam (100 scored items), so the “approximate scored items” column below is a planning aid, not a promise that your particular adaptive form will hit those counts exactly.
- Area Competency Statement title Weight Approx. scored items (of 100)
- 1 Licensure / Personnel 22% ~22
- 2 Pharmacist Practice 33% ~33
- 3 Dispensing Requirements 24% ~24
- 4 Pharmacy Operations 21% ~21
Area 1 (22%) tests who may practice and on what terms: pharmacist and pharmacist-in-charge qualifications and duties; intern and technician scope; examinations, internships, competency, and renewals; disciplinary classifications; and programs for practitioners who cannot practice safely. Connecticut overlay: Commission of Pharmacy structure, intern-hour rules, technician registration and ratios, CE, and CGS § 20-579 discipline — later chapters in this guide.
Area 2 (33%) is the largest slice. It covers issuing prescriptions and drug orders (including who may prescribe, noncontrolled and controlled issuance, and refill authority), administration and therapy-management conditions, counseling, return/reuse of drugs, public-health/quality rules, and confidentiality. Connecticut overlay: Chapter 400j prescribing and dispensing limits, EPCS, opioid supply limits, immunization and CDTM authority, counseling, HIPAA plus state confidentiality, and take-back rules.
Area 3 (24%) is the dispensing-process cluster: legitimate medical purpose and corresponding responsibility, transfers, prospective DUR (including PMP/CPMRS access and reporting), exceptions, labeling, packaging, conditions that prohibit dispensing, and nonprescription/behind-the-counter distribution. This is where CPMRS query mistakes and substitution/labeling details become expensive.
Area 4 (21%) is operations: ordering and distribution records, inventories (including Connecticut’s perpetual Schedule II expectation), storage and security, hazardous drugs, nonpharmacist access, delivery, product selection, compounding, central fill, and the permit/inspection/discipline of the pharmacy as a business setting.
The more-restrictive-law heuristic
NABP states that the MPJE makes no distinction between federal and state jurisprudence questions. You must answer in terms of the prevailing laws of the state in which you are seeking licensure . For this exam that state is Connecticut .
When federal law and Connecticut law address the same act and one is stricter , apply the stricter requirement. That is the exam’s governing heuristic, and it is also how a competent Connecticut pharmacist is expected to practice. Federal law is never “off the table,” and Connecticut law is never optional.
A concrete illustration, without jumping ahead to every numeric limit later chapters will cite: the federal Controlled Substances Act does not impose Connecticut’s first-time outpatient opioid 7-day supply rule. Connecticut does. On an MPJE item about an initial oxycodone fill for an adult in Stamford, the correct legal ceiling is the Connecticut limit, not “whatever the CSA omits.” Conversely, if a federal rule is tighter than a Connecticut counterpart on another point, the federal floor still binds. Later chapters walk CGS Chapter 400j, RCSA 20-576, Chapters 420b and 420c, CPMRS, and the DCP prescribing-practice materials against the CSA and DEA so you can see which side is tighter on each issue. Do not invent a Connecticut number when you have not confirmed it; look it up, then apply the tighter confirmed rule.
Scoring, results, and what a Fail report is for
The MPJE is computer-adaptive . Subsequent items are selected from the bank based on your running performance. A string of items that suddenly feel “easier” or “harder” is not a reliable live scoreboard; do not change strategy mid-exam based on perceived difficulty. Commit, move on, and protect the clock so you reach item 120.
The passing standard is a scaled 75 on a 0–100 scale — the figure Connecticut DCP still publishes as the required passing score. NABP’s bulletin, however, reports the candidate-facing result as Pass or Fail and does not display the numeric scaled score. Plan for a binary posting in e-Profile , commonly within 14 business days for jurisdictions on NABP’s online results platform. Remember the 107-item floor: fewer than 107 completed items typically yields no reported result ; 107–119 completed items still penalizes blanks .
If the result is Fail , NABP provides a candidate performance report broken out by competency area. Use it. A Pass result does not include that detailed report. In either case, posting of a pass does not constitute a license . Only the Commission of Pharmacy can issue one, and only after NAPLEX, MPJE, hours, application, and any other statutory conditions are complete.
Retakes
NABP allows 5 MPJE attempts per jurisdiction . The UMPJE has a separate 5-attempt total cap; that cap is irrelevant to a Connecticut-only candidate except as a reminder not to confuse the two products.
If you do not pass, you start the NABP application process again . That means a new $100 eligibility application , board reconfirmation of eligibility, a new $170 exam purchase , and a new ATT. NABP’s help center states that candidates must adhere to the waiting period before the next ATT. The standard MPJE waiting period used across NABP materials and the bulletin discussion of retakes is 30 days from the failed attempt. Do not schedule a “next Saturday” sitting; the wait is mandatory. Connecticut does not publish a longer local wait that replaces NABP’s 30-day rule; unless DCP notifies you otherwise, budget 30 days + re-eligibility processing + ATT scheduling . Each Fail counts toward the five-attempt jurisdiction maximum, so a Fail is expensive in money, calendar, and remaining attempts.
A Connecticut-specific study strategy
Treat the exam as federal core + Connecticut overlay , mapped onto the four Competency Statement weights — not as two unrelated classes. Area 2 (33%) and Area 3 (24%) together are more than half the scored exam; do not spend 80% of your hours on technician ratios and then under-prepare corresponding responsibility, CPMRS, labeling, and opioid limits.
Official sources to keep open while you study:
NABP: MPJE program page, Competency Statements (through exams before March 1, 2027), and the Candidate Application Bulletin (fees, ATT, test-day, retake, NDA).
Connecticut DCP: Commission of Pharmacy license pages, pharmacist-by-examination and score-transfer instructions, and the Comprehensive Drug Laws compilation (hard copies are no longer issued; download from DCP).
Statutes and regulations: CGS Chapter 400j (Pharmacy Practice Act); RCSA 20-576 (pharmacy regulations); CGS Chapters 420b and 420c (controlled-substance and related law); DCP pages on CPMRS , EPCS , and opioid prescribing limits .
A practical sequence that matches how items are written:
Lock the exam mechanics in this chapter so you never lose a sitting to ID, ATT, or the 107-item rule.
Map who regulates what in Connecticut (Commission, DCP, DCP Drug Control, DEA, FDA) and the more-restrictive heuristic.
Build Area 1 personnel rules (license, intern, technician, PIC, CE, discipline) from Chapter 400j and RCSA 20-576.
Build federal CS + Connecticut CS as one stack (schedules, forms, EPCS, CPMRS, opioid limits, perpetual CII).
Drill Areas 2–3 as workflow: issue → DUR/CPMRS → dispense/label/package/counsel → transfer/return.
Finish Area 4 operations: records, inventories, security, compounding, permits.
Sit NABP’s Pre-MPJE (40 items, NABP product) as a format check after the content is in place, not as your first exposure to Connecticut law.
Two candidate calendars:
New graduate. Start Chapter 400j and RCSA 20-576 during APPEs, not the week of the ATT. File DCP and NABP in parallel so intern-hour seals and eligibility are not the long pole. Sit NAPLEX and the CT MPJE far enough apart that a Fail on one does not collide with the other’s ATT expiration, but close enough that you are not re-learning federal CS twice.
Score-transfer pharmacist. You may be fluent in another state’s MPJE. That fluency is a liability if you import the other state’s technician ratio, PDMP trigger, or opioid day’s-supply into a Connecticut item. Re-read Connecticut text — especially CPMRS, opioid limits, technician ratios, and permit/hours rules — rather than “translating” your old state.
The rest of this guide is the Competency Statement map with a Connecticut overlay. Every later chapter should be read with one question in mind: what does federal law require, what does Connecticut require, and which is stricter?